About the Company Year of Establishment 2018 Legal Status of Firm Individual - Proprietor Nature of Business Wholesale Supplier Number of Employees Upto 10 People Annual Turnover Upto Rs. 50 Lakh IndiaMART Member Since Nov 2019 GST 27FCVPS4162M1ZJ Exports to United Kingdom Established in the year 2018 at Pune, Maharashtra We "Medshipper" is a Proprietor based firm, engaged as the foremost Wholesale Supplier of Pharmaceutical Injection and Pharmaceuticals Tablets. We ensure to timely deliver these products to our clients, through this we have gained a huge clients base in the market.
The company is proficient is manufacturing, exporting and supplying highly acclaimed Anti Inflammatory and Analgesic Tablets. Customers can avail Anti Inflammatory and Analgesic Tablets like K-gesic tablets from us as per the requirement. We recommend the prescribed dosage of our Anti Inflammatory and Analgesic Tablets for effective pain treatment.
Composition : Ibuprofen IP 400 MG + Paracetamol IP 500 MG
Caution : Bronchospam may be precipitated in patient suffering from or with a previous history of bronchial asthma. Ibuprofen should not to be given to patients in whom aspirin and other non-steroidal anti inflammatory drugs induce the symptoms of asthma, rhinitis or urticaria.
products covering various therapeutic segments. SHMN has private label license agreements with two companies to produce pharmaceuticals and OTC products. The Company’s manufacturing facility, located in India, enables low production costs without compromising quality. SHMN develops, manufactures and markets generic pharmaceuticals in various dosage forms, including tablets and capsules, creams and topicals, ointments, liquids and injectables. At present, SHMN has global licenses to manufacture 30 products and approximately 300 generic drugs and product formulations for distribution. SHMN markets and sells its generic drugs globally but focuses primarily on emerging markets in Africa, Latin America, Southeast Asia and the European Union. The Company’s global headquarters is located in North America and it has offices in China, India and the U.K.
The Company’s manufacturing facility is located in Ahmedabad City, India, in an area considered one of the safest in India and perfect for pharmaceutical operations. The facility is approximately 10,500 square feet and the entire land area is approximately 15,000 square feet. There is additional space available for future capacity expansions and growth and storage requirements. In February 2009, SHMN’s manufacturing facility was licensed by the India FDA. The license indicates compliance with Current Good Manufacturing Practice (CGMP) Regulations: Division of Manufacturing and Product Quality and compliant with World Health Organization (WHO) regulations.
The manufacturing facility provides complete technical support for production activities and houses the following:
? A quality control laboratory with instruments to provide, chemical and microbiological analytical support; to provide constant in process checks
? A spacious raw materials storage area which provides separate storage facilities for incoming materials, quarantine materials, released materials and a separate section for sampling under controlled environment and isolated areas for dispensing of raw materials; through documented SOPs for stringent control systems of checks and balances.
? A finished goods warehouse for storage and distribution of finished goods.
Company Overview SOHM, Inc. (SHMN) is a pharmaceutical manufacturer that produces and markets generic drugs for all major treatment categories. In February, 2009, the Company obtained a direct manufacturing license under Current Good Manufacturing Practice (CGMP) and initiated processes to be compliant with World Health Organization (WHO) regulations to produce
generic as well as OTC pharmaceuticals. This authorization process provides the Company with manufacturing competencies for a wide variety of products covering various therapeutic segments. SHMN has private label license agreements with two companies to produce pharmaceuticals and OTC products.
The Company’s strategic manufacturing facility enables low production costs without compromising quality. SHMN develops, manufactures and markets generic pharmaceuticals in various dosage forms, including tablets and capsules, creams and topicals, ointments, liquids and injectables. At present, SHMN has global licenses to manufacture more than 15 products and approximately 300 generic drugs and product formulations for distribution.
SHMN markets and sells its generic drugs globally but focuses primarily on emerging markets in Africa, Latin America, Southeast Asia and the European Union. The Company’s global headquarters is located in North America and it has offices in China, India and the U.K.
Market Data 
Markets 
AI
